Molecular Imaging Pioneer, Sanjiv “Sam” Gambhir, Dies at 57

The Stanford Medical School professor’s research aided the development of positron emission tomography (PET) reporters to identify disease.

Written byLisa Winter
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

ABOVE: © STEVE FISCH/STANFORD MEDICINE

Sanjiv “Sam” Gambhir, a giant in molecular imaging, died on July 18 of cancer at the age of 57. He was a professor and department head at Stanford University and is best known for his work developing tracers to identify abnormal cell activity using positron emission tomography (PET).

“Sam was a true visionary and a scientist of the highest caliber. His research and innovations have, with no uncertainty, founded modern medicine’s approach to early disease diagnostics and will continue to guide the future of precision health,” Stanford School of Medicine Dean Lloyd Minor says in a statement. “Sam’s contributions to Stanford, to human health, to the science of diagnostics and to the many lives he has touched and impacted throughout his career have been immeasurable.”

Born in India, Gambhir immigrated to Arizona as a young child and graduated from Arizona State University with a degree ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Lisa joined The Scientist in 2017. As social media editor, some of her duties include creating content, managing interactions, and developing strategies for the brand’s social media presence. She also contributes to the News & Opinion section of the website. Lisa holds a degree in Biological Sciences with a concentration in genetics, cell, and developmental biology from Arizona State University and has worked in science communication since 2012.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies